. "7 Risk Communication to Physicians and Patients." HIV and the Blood Supply: An Analysis of Crisis Decisionmaking. Washington, DC: The National Academies Press, 1995.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
HIV and the Blood Supply: An Analysis of Crisis Decisionmaking
Clinical Options
Status and Sources of Recommendations
Date Recommended
Surgical Procedures Elective surgical procedures should be evaluated for possible delay
MASAC
January 14, 1983
Physicians should strictly adhere to medical implications for transfusions, and autologous blood transfusions are encouraged
PHS
March 4, 1983
Heat-Treated Products Expedite the development of processing methods to inactivate viruses potentially present in AHF concentrate
MASAC
December 2, 1983
Physicians should strongly consider changing to heat-treated AHF concentrate
MASAC
October 13, 1984 (FDA licensed first heat-treated product March 1983; all four companies licensed by October 1984)
Secondary Transmission Warnings
Use condoms or practice safe sex
Not recommended
Open discussion between sexual partners and advice from physicians
NHF no recommendation by MASAC
February 3, 1984
disease before AHF concentrate became the standard treatment in the mid- to late 1970s. It is more difficult to treat adults who have severe hemophilia with the cryoprecipitate or fresh frozen plasma because of the large amount that is
